Skip to content
  • Tuesday, 29 September 2026
  • 11:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Merck KGaA and Remepy Forge Groundbreaking Partnership to Pioneer "Hybrid Drugs" for Rare Cancers
Pharmaceutical R&D

Merck KGaA and Remepy Forge Groundbreaking Partnership to Pioneer "Hybrid Drugs" for Rare Cancers

Teuku Ryan Apr 28, 2026 0

In a move that signals a significant shift in pharmaceutical innovation, Merck KGaA has announced a strategic collaboration with Remepy,…

Read More
Pharmaceutical R&D

Merck KGaA Acquires JSR Life Sciences’ Chromatography Business to Bolster Biopharmaceutical Purification Capabilities

Teuku Ryan Apr 3, 2026 0

Germany-based Merck KGaA, a leading science and technology company, has officially completed its previously announced acquisition of the chromatography business…

Read More
Science News A Century of Commitment to Scientific Literacy and Public EngagementFederal University of Technology Owerri Researchers Identify Water-in-Diesel Emulsion as a Sustainable Solution for Global Engine Emission ReductionUnlocking the Bone Marrow Microenvironment: How Chronic Inflammation Fuels Pre-Leukemic States and Age-Related Blood CancersMidlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ